{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T17:59:11Z","timestamp":1720807151624},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism Open"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.metop.2019.100013","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T04:21:13Z","timestamp":1560313273000},"page":"100013","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Could hyperglycemia-induced cardiac autoimmunity be hidden behind cardiovascular disease in type 1 diabetes mellitus?"],"prefix":"10.1016","volume":"3","author":[{"given":"Natalia","family":"Vallianou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Dalamaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metop.2019.100013_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/08916930701619169","article-title":"Autoantibodies in type 1 diabetes","volume":"41","author":"Taplin","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.metop.2019.100013_bib2","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.metop.2019.100013_bib3","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2337\/dc15-1429","article-title":"Type 1 Diabetes TrialNet Study Group. Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a Consensus Report","volume":"38","author":"Wherrett","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metop.2019.100013_bib4","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2017.17070","article-title":"Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group. Effect of oral insulin on prevention of diabetes in relatives of patients with type 1 diabetes: a randomized clinical trial","volume":"318","author":"Krischer","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.metop.2019.100013_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The diabetes control and complications trial\/epidemiology of diabetes Interventions and complications study at 30 years: overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metop.2019.100013_bib6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2337\/db13-0881","article-title":"Impact of C-peptide preservation on metabolic and clinical outcomes in the diabetes control and complications trial","volume":"63","author":"Lachin","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.metop.2019.100013_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/dc14-1656","article-title":"Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation","volume":"38","author":"Brooks","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metop.2019.100013_bib8","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metop.2019.100013_bib9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/CIRCULATIONAHA.118.036068","article-title":"Glycemic control, cardiac autoimmunity, and long-term risk of cardiovascular disease in type 1 diabetes mellitus","volume":"139","author":"Sousa","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.metop.2019.100013_bib10","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/CIRCULATIONAHA.118.038137","article-title":"Excess cardiovascular risk in type 1 diabetes mellitus","volume":"139","author":"Petrie","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.metop.2019.100013_bib11","doi-asserted-by":"crossref","first-page":"138ra80","DOI":"10.1126\/scitranslmed.3003551","article-title":"Myocardial infarction triggers chronic cardiac autoimmunity in type 1 diabetes","volume":"4","author":"Gottumukkala","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.metop.2019.100013_bib12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2337\/dc17-0806","article-title":"Type 1 diabetes TrialNet: a multifaceted approach to bringing disease-modifying therapy to clinical use in type 1 diabetes","volume":"41","author":"Bingley","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metop.2019.100013_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/dc13-0626","article-title":"B-lymphocyte depletion with rituximab and \u03b2-cell function: two-year results","volume":"37","author":"Pescovitz","year":"2014","journal-title":"Diabetes Care"}],"container-title":["Metabolism Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936819300131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936819300131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T12:00:48Z","timestamp":1568635248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589936819300131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":13,"alternative-id":["S2589936819300131"],"URL":"https:\/\/doi.org\/10.1016\/j.metop.2019.100013","relation":{},"ISSN":["2589-9368"],"issn-type":[{"value":"2589-9368","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could hyperglycemia-induced cardiac autoimmunity be hidden behind cardiovascular disease in type 1 diabetes mellitus?","name":"articletitle","label":"Article Title"},{"value":"Metabolism Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metop.2019.100013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100013"}}